OMTrigger Inject- Treating Trigger Points: Comparing Muscle Energy Technique vs. Lidocaine Needling Technique
Treating Trigger Points: Comparing Muscle Energy Technique vs. Lidocaine Needling Technique for Pain Control and Quality of Life Measurements
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Myofascial pain syndrome is one of the most common musculoskeletal disorders seen in the aging US population. Its characterized by myofascial trigger points (MTPs) which were defined as hyperirritable nodules in a taut band of skeletal muscle, associated with pain on manual stretching, contraction, or stimulation of the muscle. Trigger points are further classified into active and latent based on their clinical features. Active MTPs are characterized by spontaneous pain at rest with referred pain on palpation whereas latent MTPs produce pain on palpation in addition to restriction of range of motion.
Currently, there are a variety of treatment options for MTPs including lidocaine injections, dry needling, osteopathic manipulative treatment, massage therapy, ultrasound therapy etc. There has been a lot of research investigating the safety and efficacy of dry needling and lidocaine trigger point injection techniques in treating MTPs. It was found that dry needling and lidocaine injections were both equally effective in reducing symptoms associated with MTPs as it was the mechanical disruption of the taut fibers due to the needle effect and the depth of adequate penetration that resulted in pain reduction more than the substance actually delivered into the muscle. Some authors also suggested the importance of a local twitch response (LTR); which is an observable contraction of the taut part of muscle band upon stimulation, during dry needling technique as being pertinent for maximum effectiveness. However, a recent systemic review found that LTR during dry needling treatment was unnecessary and not required for management of myofascial pain syndrome.
On the other hand, there has been fewer research investigating the effects of manual treatment on trigger points. Reasearchers had initially treated trigger points with ischemic compression but later changed their recommendation to applying gentle digital pressure to trigger points. A recent study done on traction-compression-stretch technique (TTCE) compared with ischemic compression showed some, albeit minor, increased outcome measures (pain pressure threshold) warranting clinical investigation. Another study compared active release and muscle energy techniques in treating latent trigger points of the upper trapezius and found that both techniques were equally effective in increasing cervical range of motion and decreasing pain and upper trapezius thickness. Other studies have also shown interest in similar osteopathic manipulative techniques such as counterstrain, myofascial release, facilitated positional release and high velocity-low amplitude thrust techniques in treating trigger points.
Studies have showed that the upper trapezius is one of the most common muscles affected by myofascial pain syndrome leading to referred pain manifesting as headaches and stiff neck.
Currently, there is no consensus as to which treatment method is superior, with the decision to treat in a certain way largely based upon the training received by the individual physician rather than the characteristics of the trigger point itself. There are no studies to date evaluating the efficacy of the various treatment options specifically osteopathic manipulative treatment vs. trigger point injections. Thus, the intention of the present study is to determine the efficacy rates of muscle energy techniques vs. lidocaine injections in treating MTPs in the upper trapezius region.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
New Jersey
-
Atlantic City, New Jersey, United States, 08401
- AtlantiCare Regional Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
The subjects will only be recruited into the study if participants have met all the following criteria:
- Ages between 25 and 75 years.
- Previous or current diagnosis of MTrP in the upper trapezius region according to the criteria in reference
- 1 active/latent MTrP in the upper trapezius region
The diagnostic criteria to establish myofascial trigger point is adopted from prior investiogators and include:
- Presence of palpable taut band in the skeletal muscle
- Presence of hypersensitive tender spot in the taut band
- Presence of local twitch response upon stimulation of the taut band
- Reproduction of referred pain upon palpation
- Presence of spontaneous referred pain pattern
Exclusion Criteria:
- Exclusion criteria: Any subject that exhibits any of the following criteria will excluded from the study:
- Pregnancy or immunocompromise
- Fever/infection
- Previous history of whiplash injury
- Previous history of cervical surgery, cervical radiculopathy, or myelopathy
- Severe disc or cervical lesion
- Evidence of cognitive deficit
- Degenerative or inflammatory disease of the cervical spine or shoulder, fibromyalgia, or neuromuscular diseases
- Use of medications (anticoagulants, anti-inflammatory etc.) or illicit drug use (1 week prior to treatment or follow up)
- Received treatment for MPS a month before the study recruitment
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
OMT Group
This group will receive OMT muscle energy as treatment for myofascial pain syndrome
|
OMT will be performed on identified areas of trapezius trigger points
Other Names:
|
|
Injection Group
This group will receive lidocaine injections for myofascial pain syndrome
|
OMT will be performed on identified areas of trapezius trigger points
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity
Time Frame: Prior to intervention
|
0-10, measured using a point system; where 0 = no pain and 10 = maximum pain.
|
Prior to intervention
|
|
Measurement on quality of life, evaluate neck and upper extremity function.
Time Frame: Prior to intervention
|
Utilizing the neck disability index score which is used to evaluate neck and upper extremity function.
The total score is divided by number of answered questions, subtracted 1 and multiplied by 25, in a scale score that range from 0 to 100, with higher scale scores indicating more disability.
|
Prior to intervention
|
|
Pain Intensity
Time Frame: Immediately after intervention
|
0-10, measured using a point system; where 0 = no pain and 10 = maximum pain.
|
Immediately after intervention
|
|
Measurement on quality of life, evaluate neck and upper extremity function.
Time Frame: immediately after intervention
|
Utilizing the neck disability index score which is used to evaluate neck and upper extremity function.
The total score is divided by number of answered questions, subtracted 1 and multiplied by 25, in a scale score that range from 0 to 100, with higher scale scores indicating more disability.
|
immediately after intervention
|
|
Pain Intensity
Time Frame: 1 week after intervention
|
0-10, measured using a point system; where 0 = no pain and 10 = maximum pain.
|
1 week after intervention
|
|
Measurement on quality of life, evaluate neck and upper extremity function.
Time Frame: 1 week after intervention
|
Utilizing the neck disability index score which is used to evaluate neck and upper extremity function.
The total score is divided by number of answered questions, subtracted 1 and multiplied by 25, in a scale score that range from 0 to 100, with higher scale scores indicating more disability.
|
1 week after intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Brendan S Kelly, DO, AtlantiCare Regional Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB 2021-1045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myofascial Pain Syndrome
-
NCT07278570RecruitingMyofascial Pain | Myofascial Pain Syndrome - Lower Back
-
NCT07395154Not yet recruiting
-
NCT07630909CompletedMyofascial Pain Syndrome (MPS)
-
NCT07351331CompletedMyofascial Pain Syndrome (MPS)
-
NCT07397039Completed
-
NCT05851326RecruitingMyofascial Pain Syndrome - Lower Back | Myofascial Pain Syndrome - Neck | Myofascial Pain Syndrome - Tension Headache
-
NCT07609173CompletedMyofascial Pain Syndrome (MPS)
-
NCT06273514CompletedMyofascial Trigger Point Pain | Myofascial Pain Syndrome of Neck | Myofascial Trigger Point Syndrome
-
NCT07593586Completed
-
NCT01189994UnknownFibromyalgia | Myofascial Pain Syndrome, Diffuse | Diffuse Myofascial Pain Syndrome | Fibromyalgia-Fibromyositis Syndrome | Fibromyositis-Fibromyalgia Syndrome
Clinical Trials on OMT
-
NCT05824520RecruitingCoronary Artery Disease | Myocardial Ischaemia
-
NCT04520386UnknownBreast Cancer | Pancreatic Cancer | Lung Cancer
-
NCT03663322RecruitingType2 Diabetes Mellitus | Osteopathy in Diseases Classified Elsewhere
-
NCT05889039Completed
-
NCT02054650TerminatedType 2 Diabetes Mellitus | Chronic Low Back Pain
-
NCT01132495Completed
-
NCT02592850WithdrawnTension-Type Headache
-
NCT04976985Enrolling by invitationMigraine Disorders | Headache Disorders | Chronic Migraine | Headache, Migraine
-
NCT05580640CompletedKnee Arthroplasty | Gait, Unsteady | Osteopathic Manipulative Treatment | Knee Arthroscopy